New substance overcomes treatment-restistance in leukemia
Successful tests in cultures and mouse models for Philadelphia chromosome positive leukemia through German-Russian collaboration
2014-12-01
(Press-News.org) This news release is available in German.
FRANKFURT The chances of patients with Philadelphia chromosome-positive leukaemia (Ph+) being cured has greatly increased in recent years. Nevertheless, a high percentage of patients have developed resistance to available medication. But now, haematologists from Frankfurt, working with a Russian pharmaceutical company, have developed a new active substance that effectively combats the most aggressive forms of Philadelphia chromosome-positive leukaemia, both in vitro and in vivo. They have reported this in the current edition of the renowned specialist journal 'Leukaemia'.
Patients with the Philadelphia chromosome develop chronic myelogenous leukaemia (CML) or acute lymphatic leukaemia (Ph+ ALL). These are the first types of leukaemia that are able to be treated due to the development of targeted molecular therapy. Selective kinase inhibitor active substances act directly on the cancer-inducing gene BCR/ABL. However, after a while, the treatment becomes ineffective for many patients - either due to BCR/ABL mutations or due to other mechanisms that are as yet unknown. At present, there is only one substance, Ponatinib, which is able to overcome nearly all clinical resistance. Unfortunately, Ponatinib can only be used with extreme caution due to some of its life-threatening side-effects.
Moscow-based company Fusion Pharma has developed an innovative kinase inhibitor, PF-114 with the aim of having the same effect on Ph+ leukaemia as Ponatinib, but with reduced side-effects. In the current edition of 'Leukaemia', the team led by Dr. Afsar Mian, Professor Oliver Ottmann and lecturer Dr. Martin Ruthardt from the Haematology Department of Medical Clinic II, have reported that PF-114 is as effective as Ponatinib against resistant Ph+ leukaemia.
"These results provide the basis for the administration of PF-114 in treatment-resistant patients with Ph+ leukaemia. The favourable efficacy and good side effect profile now need to be further tested on patients in clinical phase I studies," explained Dr. Ruthardt. "PF-114 would not have reached this level of development without our colleagues in Frankfurt. On the basis of this data, in the first half of 2015, we will be able to start international phase I studies," explains Dr. Ghermes Chilov, CEO of Fusion Pharma, the company that financed the project.
INFORMATION:
Publication:
Mian et al.: PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome- positive (Ph+) leukaemias harbouring the T315I mutation, in Leukemia, 14. November 2014, doi: 10.1038/leu.2014.326.
Information: Lecturer Dr. Martin Ruthardt, Haematology/Medical Clinic II, University Clinic, Tel. ++49(0)69 6301-5338, ruthardt@em.uni-frankfurt.de.
The Goethe University is an institution with particularly strong research capabilities based in the European financial metropolis of Frankfurt. It celebrates its 100th year of existence in 2014. The university was founded in 1914 through private means from liberally-orientated citizens of Frankfurt and has devoted itself to fulfilling its motto "Science for the Society" in its research and teaching activity right up to the present day. Many of the founding donors were of Jewish origin. During the last 100 years, the pioneering services offered by the Goethe University have impacted the fields of social, societal and economic sciences, chemistry, quantum physics, neurological research and labour law. On January 1st, 2008, it achieved an exceptional degree of independence as it returned to its historical roots as a privately funded university. Today it is one of the ten universities that are most successful in obtaining external research funding and one of the three largest universities in Germany with centres of excellence in medicine, life sciences and humanities.
Publisher: The president of the Goethe University Frankfurt am Main. Editorial department: Dr. Anke Sauter, Science editor, Department Marketing and Communications, Grüneburgplatz 1, 60629 Frankfurt am Main, Phone: ++49(0)69 798-12498.
ELSE PRESS RELEASES FROM THIS DATE:
2014-12-01
Tropical Depression 21W crossed the Philippines and moved into the South China Sea where warm waters helped strengthen the storm into Tropical Storm Sinlaku. NASA's Aqua satellite passed over the storm and captured an image that showed it appeared elongated.
Despite the strengthening of Tropical Depression 21W into a tropical storm on Nov. 28, it appeared elongated from southwest to northeast on visible imagery taken by the Moderate Resolution Imaging Spectroradiometer (MODIS) instrument that flies aboard Aqua. The MODIS image also showed that the strongest thunderstorms ...
2014-12-01
NASA's Terra satellite passed over Tropical Cyclone 02S after it formed in the Southern Indian Ocean on Nov. 28. An image from Terra showed that the new tropical storm is close to Mauritius and Reunion Islands.
The Moderate Resolution Imaging Spectroradiometer or MODIS instrument aboard NASA's Terra satellite captured a visible image of newborn Tropical Cyclone 02S northeast of the islands of Mauritius and Reunion. The MODIS image showed that thunderstorms were mostly west of the low-level center of circulation and bands of thunderstorms were wrapping into the center. ...
2014-12-01
This news release is available in German. Humans don't like being alone, and their genes are no different. Together we are stronger, and the two versions of a gene - one from each parent - need each other. Scientists at the Max Planck Institute for Molecular Genetics in Berlin have analysed the genetic makeup of several hundred people and decoded the genetic information on the two sets of chromosomes separately. In this relatively small group alone they found millions of different gene forms. The results also show that genetic mutations do not occur randomly in the ...
2014-12-01
Two physicists from the University of Warwick have taken to the kitchen to explain the complexity surrounding what they say is one of the last big mysteries in polymer physics.
As a way of demonstrating the complicated shapes that ring-shaped polymers can adopt, the researchers have created a brand new type of ring-shaped pasta, dubbed "anelloni" (anello being the Italian word for "ring"), which they've exclusively unveiled in this month's Physics World.
With just 2 eggs and 200 g of plain flour, Davide Michieletto and Matthew S Turner have created large loops of pasta ...
2014-12-01
Peter Friedl, M.D., Ph.D., professor of genitourinary medical oncology at The University of Texas MD Anderson Cancer Center, has received one of Italy's top scientific awards for his work in imaging and cancer growth, metastasis and therapy response.
Friedl was named a recipient of the 13th annual City of Florence Prize in Molecular Sciences. Previous recipients include such scientific luminaries as AIDS research pioneer Robert C. Gallo. M.D., human genome sequencing expert J. Craig Venter, Ph.D., and Nobel laureates Robert Hubert, Ph.D. and Ada Yonath, Ph.D. Friedl received ...
2014-12-01
Replenishing the supply of a molecule that normally activates cannabinoid receptors in the brain could relieve mood and anxiety disorders and enable some people to quit using marijuana, a Vanderbilt University study suggests.
Cannabinoid receptors are normally activated by compounds in the brain called endocannabinoids, the most abundant of which is 2-AG. They also are "turned on" by the active ingredient in marijuana.
Sachin Patel, M.D., Ph.D., and his colleagues developed a genetically modified mouse with impaired ability to produce 2-AG in the brain. The mice exhibited ...
2014-12-01
This research is being carried out under the auspices of MAGDRIVE, a European research project coordinated by Professor José Luis Pérez Díaz, from the UC3M Instituto Pedro San Juan de Lastanosa, in which seven European entities participate. It consists of the development of a magnetic gear reducer, that is, a mechanism that transforms speed from an input axle to another in an output axle (as in a bicycle chain mechanism or the gearbox of an automobile). But in this case, unlike a conventional gear reducer, this transmission is produced without contact between ...
2014-12-01
Astronomers have measured the passing of a super-Earth in front of a bright, nearby Sun-like star using a ground-based telescope for the first time. The transit of the exoplanet 55 Cancri e is the shallowest detected from the ground yet. Since detecting a transit is the first step in analyzing a planet's atmosphere, this success bodes well for characterizing the many small planets that upcoming space missions are expected to discover in the next few years.
The international research team used the 2.5-meter Nordic Optical Telescope on the island of La Palma, Spain, a moderate-sized ...
2014-12-01
December 1, 2014 - A study using intricate fiber dissection techniques provides new insights into the deep anatomy of the human brainstem--and helps to define "safe entry zones" for neurosurgeons performing brainstem surgery, according to a special article published in Operative Neurosurgery, a quarterly supplement to Neurosurgery, official journal of the Congress of Neurological Surgeons. These publications are published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Neurosurgeons Dr. Kaan Yagmurlu and Dr. Albert L. Rhoton, Jr, of University of Florida, ...
2014-12-01
Philadelphia, PA, December 1, 2014 - Panic disorder is a severe form of anxiety in which the affected individual feels an abrupt onset of fear, often accompanied by profound physical symptoms of discomfort. Scientists have known from studying twins that genes contribute to the risk of panic disorder, but very little is known about which specific genes are involved.
Two of the most common and terrifying symptoms of this severe anxiety are a sense of shortness of breath and feelings of suffocation. Studies have shown that breathing air that has increased levels of carbon ...
LAST 30 PRESS RELEASES:
[Press-News.org] New substance overcomes treatment-restistance in leukemia
Successful tests in cultures and mouse models for Philadelphia chromosome positive leukemia through German-Russian collaboration
